Products with Anticancer bioactivity
| Cat.No. | Product Name |
|---|---|
| BCN3778 | Jolkinol A |
| 1. Jolkinol A can inhibit both MCF-7 (breast adenocarcinoma), NCI-H460 (non-small cell lung cancer) cell lines, with GI50 values ranging between 40.9 microM and 95.3 microM. | |
| BCN3795 | Faradiol |
| 1. Faradiol shows inhibitory activity against 12-O-tetradecanoylphorbol-13-acetate (TPA)- induced inflammation in mice; it can inhibit markedly the tumor-promoting effect of TPA (1 ug/mouse) on skin tumor formation following initiation with 7,12-dimethylbenz[α] anthracene (50 ug/mouse). 2. Faradiol shows inhibitory effects against Epstein-Barr virus early antigen (EBV-EA) activation with potencies either comparable with or stronger than that of glycyrrhetic acid, a known natural anti-tumor-promoter. | |
| BCN3797 | Limonene |
| Limonene has antioxidant activity, it at all concentrations reveal a reduction in the frequency of MN and DNA damage induced by H2O2. | |
| BCN3810 | Arnidiol |
| 1. Arnidiol shows inhibitory effects against Epstein-Barr virus early antigen (EBV-EA) activation with potencies either comparable with or stronger than that of glycyrrhetic acid, a known natural anti-tumor-promoter; it also possesses a wide range of cytotoxicity against human cancer cell lines, with GI50 values (concentration that yields 50% growth) of mostly less than 6 microM. 2. Arnidiol, heliantriol B0, heliantriol C and arnidiol possess marked inhibitory activity against 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced inflammation in mice, the 50% inhibitory dose of these compounds with respect to TPA-inflammation (1 microgram) is 0.03-0.2 mg/ear, suggests that they have anti-inflammatory activity. | |
| BCN3821 | Linoleic acid |
| Essential fatty acid. Prostaglandin precursor. | |
